Jun 30, 2026 04:04AM
Jun 29, 2026 08:00AM
Jun 26, 2026 08:01AM
Jun 26, 2026 08:00AM
Jun 1, 2026 02:53AM
Jun 1, 2026 01:06AM
May 31, 2026 08:00AM Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 30, 2026 08:00AM
May 29, 2026 08:01AM
May 29, 2026 08:00AM
May 12, 2026 12:50PM
May 8, 2026 01:32PM
Apr 27, 2026 08:00AM
Apr 13, 2026 03:41AM BMO Capital Downgrades Replimune Group (REPL) to Underperform
Apr 13, 2026 01:54AM
Apr 10, 2026 05:04PM
Apr 10, 2026 05:02PM
Apr 10, 2026 04:16PM
Apr 10, 2026 01:20PM
Apr 10, 2026 11:19AM
Feb 3, 2026 08:00AM Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 12, 2025 07:43AM
Nov 7, 2025 04:45PM
Nov 7, 2025 04:45PM
Nov 6, 2025 08:00AM
Nov 3, 2025 12:04AM
Oct 27, 2025 06:44AM
Oct 20, 2025 10:20AM Leerink Partners Upgrades Replimune Group (REPL) to Outperform
Oct 20, 2025 08:59AM
Oct 20, 2025 07:02AM
Oct 20, 2025 07:00AM
Oct 19, 2025 08:00AM
Sep 19, 2025 06:51AM
Sep 18, 2025 09:15AM
Sep 18, 2025 09:15AM Replimune Provides Update Following Type A Meeting with FDA
Sep 9, 2025 06:50AM
Sep 2, 2025 08:02AM
Sep 2, 2025 08:00AM
Aug 11, 2025 05:30AM
Aug 7, 2025 08:00AM
Aug 1, 2025 07:48AM
Jul 31, 2025 02:12PM Important Notice to Long-term Shareholders of Replimune Group, Inc. (REPL): Grabar Law Office Investigates Claims on Your Behalf
Jul 30, 2025 08:49AM
Jul 29, 2025 03:19PM
Jul 28, 2025 10:00AM
Jul 27, 2025 09:58AM
Jul 22, 2025 04:31PM
Jul 22, 2025 01:19PM
Jul 22, 2025 12:31PM Leerink Partners Reiterates Outperform Rating on Replimune Group (REPL), PT $21, 'Estimates Under Review'
Jul 22, 2025 11:18AM

325,726 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All